Nutra Pharma Corp (NPHC) stock
NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $806.69KP/E –Yield –
Nutra Pharma profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Nutra Pharma's profit margin for the twelve months ending Jun 30, 2026 was -3370.6%. For fiscal 2025 it was -794.8%, against -522.0% the year before. The highest annual figure on record is 5608.3% in fiscal 2022.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -794.8% | −272.8 |
| FY2024 | Dec 31, 2024 | -522.0% | +155.8 |
| FY2023 | Dec 31, 2023 | -677.8% | −6286.1 |
| FY2022 | Dec 31, 2022 | 5608.3% | +19007.3 |
| FY2021 | Dec 31, 2021 | -13399.0% | −11916.9 |
| FY2020 | Dec 31, 2020 | -1482.1% | +4831.9 |
| FY2019 | Dec 31, 2019 | -6314.1% | −3339.5 |
| FY2018 | Dec 31, 2018 | -2974.6% | +355.5 |
| FY2017 | Dec 31, 2017 | -3330.1% | −1282.3 |
| FY2016 | Dec 31, 2016 | -2047.8% | −196.8 |
| FY2015 | Dec 31, 2015 | -1851.0% | −1424.9 |
| FY2014 | Dec 31, 2014 | -426.1% | +3716.6 |
| FY2013 | Dec 31, 2013 | -4142.7% | −2365.7 |
| FY2012 | Dec 31, 2012 | -1776.9% | +978.2 |
| FY2011 | Dec 31, 2011 | -2755.2% | −2541.4 |
| FY2010 | Dec 31, 2010 | -213.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -11458.0% | −11895.2 |
| Q1 FY2026 | Mar 31, 2026 | -1687.1% | +212.1 |
| Q4 FY2025 | Dec 31, 2025 | -1692.5% | −1410.5 |
| Q3 FY2025 | Sep 30, 2025 | -745.3% | −397.7 |
| Q2 FY2025 | Jun 30, 2025 | 437.2% | +1147.2 |
| Q1 FY2025 | Mar 31, 2025 | -1899.2% | −767.7 |
| Q4 FY2024 | Dec 31, 2024 | -282.0% | +234.8 |
| Q3 FY2024 | Sep 30, 2024 | -347.6% | +192.0 |
| Q2 FY2024 | Jun 30, 2024 | -710.0% | −177.1 |
| Q1 FY2024 | Mar 31, 2024 | -1131.5% | −44.7 |
| Q4 FY2023 | Dec 31, 2023 | -516.8% | −4608.6 |
| Q3 FY2023 | Sep 30, 2023 | -539.6% | −2883.7 |
| Q2 FY2023 | Jun 30, 2023 | -532.9% | +1738.5 |
| Q1 FY2023 | Mar 31, 2023 | -1086.8% | −37524.5 |
| Q4 FY2022 | Dec 31, 2022 | 4091.8% | −4254.8 |
| Q3 FY2022 | Sep 30, 2022 | 2344.2% | −77762.7 |
| Q2 FY2022 | Jun 30, 2022 | -2271.5% | −13310.0 |
| Q1 FY2022 | Mar 31, 2022 | 36437.7% | +190895.6 |
| Q4 FY2021 | Dec 31, 2021 | 8346.6% | +21752.3 |
| Q3 FY2021 | Sep 30, 2021 | 80106.8% | +75711.3 |
| Q2 FY2021 | Jun 30, 2021 | 11038.5% | +35181.0 |
| Q1 FY2021 | Mar 31, 2021 | -154457.9% | −167212.3 |
| Q4 FY2020 | Dec 31, 2020 | -13405.7% | +23639.7 |
| Q3 FY2020 | Sep 30, 2020 | 4395.5% | +5556.3 |
| Q2 FY2020 | Jun 30, 2020 | -24142.5% | −7811.5 |
| Q1 FY2020 | Mar 31, 2020 | 12754.4% | +13723.5 |
| Q4 FY2019 | Dec 31, 2019 | -37045.3% | −34805.6 |
| Q3 FY2019 | Sep 30, 2019 | -1160.7% | +1040.8 |
| Q2 FY2019 | Jun 30, 2019 | -16331.0% | −11801.7 |
| Q1 FY2019 | Mar 31, 2019 | -969.1% | +2102.7 |
| Q4 FY2018 | Dec 31, 2018 | -2239.8% | +787.0 |
| Q3 FY2018 | Sep 30, 2018 | -2201.5% | +3335.5 |
| Q2 FY2018 | Jun 30, 2018 | -4529.3% | −2397.9 |
| Q1 FY2018 | Mar 31, 2018 | -3071.8% | −196.9 |
| Q4 FY2017 | Dec 31, 2017 | -3026.7% | – |
| Q1 FY2017 | Mar 31, 2017 | -5537.1% | – |
| Q2 FY2016 | Jun 30, 2016 | -2131.3% | – |
| Q1 FY2016 | Mar 31, 2016 | -2874.9% | – |
See a number that looks wrong?